Related Experiment Video
Updated: Jun 13, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Trioxaferroquines as new hybrid antimalarial drugs
François Bellot1, Frédéric Coslédan, Laure Vendier
1Laboratoire de Chimie de Coordination du CNRS, Toulouse, France.
Abstract:
The synthesis, characterization, and antimalarial evaluation of a new series of potential antimalarial molecules, named trioxaferroquines, are reported. Trioxaferroquines are hybrid antimalarial drugs containing a 1,2,4-trioxane covalently linked to ferroquine (Fq), a synthetic ferrocenylquinoline derivative currently under clinical development. The aim was to combine, within a single structure, an iron(II) species, a 1,2,4-trioxane, as in artemisinin, and a substituted quinoline, as in chloroquine.
Related Concept Videos
Antiprotozoal Agents
Anthelminthic Agents
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Antifungal Agents
Malaria

